Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Tianjin Tianyao Pharmaceuticals Co., Ltd
483
•Tianjin Tianyao Pharmaceuticals Co., Ltd•May 31, 2019

FDA 483 - Tianjin Tianyao Pharmaceuticals Co., Ltd - May 31, 2019

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

An FDA inspection of Tianjin Tianyao Pharmaceuticals Co., Ltd in Tianjin, China, revealed significant deficiencies in their manufacturing and laboratory operations. The firm failed to follow established environmental monitoring procedures for its Class D production area and maintained inadequate stability procedures for in-process products. Additionally, laboratory records for working standards were incomplete, lacking necessary requalification testing.

Company
Tianjin Tianyao Pharmaceuticals Co., Ltd
Inspection Date
May 31, 2019
Product Type
Drugs
Office
Office of Biological Products Operations - Division I
Person
  • Taichun Qin (Consumer Safety Officer, Drug Specialist)
Open in Dashboard

ID · e8d56de2-1f6d-4bda-82b3-0d99a5c0bda7

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.